Fuji Pharma Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuji Pharma Company Limited with three other
companies in this sector in Japan:
JCR Pharmaceuticals Co., Ltd.
sales of 20.59 billion Japanese Yen [US$181.64 million]
of which 98%
was Pharmaceutical Business),
Koa Shoji Holdings Co Ltd
(14.83 billion Japanese Yen [US$130.76 million]
of which 76%
was Drug substance sales business), and
Daito Pharmaceutical Company Limited
(39.88 billion Japanese Yen [US$351.71 million]
of which 52%
was Drug Substance).
Fuji Pharma Company Limited reported sales of ¥37.91 billion (US$334.36 million)
September of 2018.
increase of 7.1%
versus 2017, when the company's sales were ¥35.39 billion.
Sales at Fuji Pharma Company Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 51%).